Massimiliano di Pietro
Massimiliano di Pietro
Clinician Scientist, MRC Cancer Unit, Universtiy of Cambridge
Verified email at
Cited by
Cited by
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
RC Fitzgerald, M di Pietro, K Ragunath, Y Ang, JY Kang, P Watson, ...
Gut 63 (1), 7-42, 2014
Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial
KN Phoa, FGI Van Vilsteren, BLAM Weusten, R Bisschops, EJ Schoon, ...
Jama 311 (12), 1209-1217, 2014
Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase
L Stojic, N Mojas, P Cejka, M di Pietro, S Ferrari, G Marra, J Jiricny
Genes & development 18 (11), 1331-1344, 2004
Methylation‐induced G2/M arrest requires a full complement of the mismatch repair protein hMLH1
P Cejka, L Stojic, N Mojas, AM Russell, K Heinimann, E Cannavˇ, ...
The EMBO journal 22 (9), 2245-2254, 2003
Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement
B Weusten, R Bisschops, E Coron, M Dinis-Ribeiro, JM Dumonceau, ...
Endoscopy 49 (02), 191-198, 2017
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma
CS Ross-Innes, J Becq, A Warren, RK Cheetham, H Northen, ...
Nature genetics 47 (9), 1038-1046, 2015
Nuclear aggregates of polyamines are supramolecular structures that play a crucial role in genomic DNA protection and conformation
L D'Agostino, M Di Pietro, A Di Luccia
The FEBS journal 272 (15), 3777-3787, 2005
Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treatedá…
RJ Haidry, MA Butt, JM Dunn, A Gupta, G Lipman, HL Smart, P Bhandari, ...
Gut 64 (8), 1192-1199, 2015
DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus
MA Alvi, X Liu, M O'Donovan, R Newton, L Wernisch, NB Shannon, ...
Clinical Cancer Research 19 (4), 878-888, 2013
The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus
M di Pietro, DF Boerwinkel, MK Shariff, X Liu, E Telakis, P Lao-Sirieix, ...
Gut 64 (1), 49-56, 2015
Evidence for a functional role of epigenetically regulated midcluster HOXB genes in the development of Barrett esophagus
M di Pietro, P Lao-Sirieix, S Boyle, A Cassidy, D Castillo, A Saadi, ...
Proceedings of the National Academy of Sciences 109 (23), 9077-9082, 2012
Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers
M di Pietro, JS Bellver, M Menigatti, F Bannwart, A Schnider, A Russell, ...
Gastroenterology 129 (3), 1047-1059, 2005
Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance
YC Lim, M di Pietro, M O'Donovan, S Richardson, I Debiram, ...
Gastrointestinal endoscopy 80 (1), 78-87, 2014
British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma
M Banks, D Graham, M Jansen, T Gotoda, S Coda, M Di Pietro, N Uedo, ...
Gut 68 (9), 1545-1575, 2019
Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia
M di Pietro, RC Fitzgerald
Gut 67 (2), 392-393, 2018
Screening for Barrett’s esophagus
M Di Pietro, D Chan, RC Fitzgerald, KK Wang
Gastroenterology 148 (5), 912-923, 2015
Endoscopic management of early adenocarcinoma and squamous cell carcinoma of the esophagus: screening, diagnosis, and therapy
M di Pietro, MI Canto, RC Fitzgerald
Gastroenterology 154 (2), 421-436, 2018
The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation
M Barbera, M di Pietro, E Walker, C Brierley, S MacRae, BD Simons, ...
Gut 64 (1), 11-19, 2015
Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status
EZ Mi, EZ Mi, M di Pietro, M O’Donovan, RH Hardwick, S Richardson, ...
Gastrointestinal endoscopy 87 (2), 408-418, 2018
Barrett’s esophagus and cancer risk: how research advances can impact clinical practice
M Di Pietro, D Alzoubaidi, RC Fitzgerald
Gut and liver 8 (4), 356, 2014
The system can't perform the operation now. Try again later.
Articles 1–20